Drug
trastuzumab and hyaluronidase-oysk
Marketed as HERCEPTIN HYLECTA.
Generic name
trastuzumab and hyaluronidase-oysk
Brand names
HERCEPTIN HYLECTA
First FDA approval
2019-02-28
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761106 | HERCEPTIN HYLECTA | 2019-02-28 | GENENTECH INC |
Manufacturers
GENENTECH INC
Frequently asked questions
When was trastuzumab and hyaluronidase-oysk FDA approved?
Earliest FDA approval on record: 2019-02-28.
What brand names are sold as trastuzumab and hyaluronidase-oysk?
HERCEPTIN HYLECTA.
Sources
Appeal a trastuzumab and hyaluronidase-oysk denial
Upload the denial notice. DenialHelp helps verify the reason, organize source-linked evidence, and prepare a treating-clinician-reviewable package. Price and refund terms are shown before payment.
Get started →Contact: hello@denialhelp.com